Predictive value of seizure onset for gross motor dysfunction in individuals with pathogenic GABRB2 and GABRB3 variants.
AuteursOrtiz S, Affronte L, Bagliani C, El-Kamand S, Kan ASH, Kristoffersen IT, Dahl RS, Højte AF, Auvin S, Bouman A, Zeidler S, Kluger G, Lesca G, Chatron N, Goke-Samar Z, Papadopoulou MT, Terzi MAP, Schaefer E, de Saint Martin A, Baer S, Al Owain M, Takroni S, Al-Dhalaan H, Bonanni P, Rossi A, Zanotta N, Trivisano M, Specchio N, de Dominicis A, Striano P, Orsini A, Mancardi MM, Neuens S, Jennesson-Lyver M, Benkel-Herrenbrueck I, Genevieve D, Sidlow R, Tezcan K, Krey I, Lemke JR, Platzer K, Lederer D, Talvik I, Vaher U, Braun KPJ, Guerrot AM, More R, De Wachter M, Weckhuysen S, Carapancea E, Cilio MR, Jacobs J, Sterbova K, Balestrini S, Guerrini R, Peroni G, Mero IL, ElNaggar W, Elkhateeb N, Schmetz A, Chan DL, Mirzaa GM, Chaumette B, Legrand A, McTague A, Stödberg T, Harris RV, Berkovic SF, Scheffer IE, Chebib M, Gardella E, Ahring PK, Absalom NL, Møller RS
Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer.
AuteursLobo-Martins S, Martins-Branco D, Padonou F, Dahma H, van den Wijngaert S, Jaouart M, Dauccia C, Molinelli C, Agostinetto E, Loizidou A, Taylor D, Boisson A, Garaud S, Spilleboudt C, Vicente Cardona J, Ramge P, Balas BI, Bajji M, George F, Delsaute T, Paesmans M, Ameye L, Piccart M, de Azambuja E, Willard-Gallo K
Antimicrobial resistance of bacteria isolated in a resource-limited region: the experience of the North Kivu Provincial Reference Laboratory in the Democratic Republic of the Congo.
AuteursBusha Tibasima E, Ndeba PM, Mseza B, Sy O, Ndeba SDA, Chalhoub H, Senga R, Kihemba K, Byl B, Vandenberg O
Comparison of suboptimal versus adequate ovarian function suppression in premenopausal women with early breast cancer treated with adjuvant endocrine therapy: An exploratory analysis of two prospective studies.
AuteursNardin S, Bruzzone M, Arecco L, Chiappe E, Lanzavecchia C, Ruelle T, Giannubilo I, Razeti MG, Borea R, Barcellini L, Bruzzone F, Daneri A, Molinelli C, Soldato D, Levaggi A, Bighin C, Barbero V, Ottonello S, Scavone G, Fregatti P, Spinaci S, Cardinali B, Tagliamento M, Blondeaux E, Lambertini M, Del Mastro L, Poggio F
Validation of PREDICT tool v2.2 in patients with early-stage breast cancer enrolled in the GIM and MIG trials.
AuteursBorea R, Blondeaux E, Carmisciano L, Arecco L, Perachino M, Poggio F, Ruelle T, Luelli F, de Laurentiis M, Arpino G, Puglisi F, Fabi A, Gori S, Fregatti P, Lambertini M, Boni L, Del Mastro L
AuteursPansieri J, Figiel S, Menassa D, Ricigliano VAG, Seferoglu M, Borrelli S, Szejko N, Samadzadeh S, Boldrini V, Zarco L, Correa-Díaz EP, Pozzilli V, Marenna S, Carnero Contentti E, Koc ER, Dalla Costa G, Casallas-Vanegas A, Bakirtzis C, Gluscevic S, Tunç A, Gomez Figueroa E
